Council has £300m property debt despite sell-off
A local authority has to pay off nearly £300m of loans with interest despite selling the properties bought with the money.
Somerset Council is in the process of selling the shops and offices in its commercial property portfolio, which it inherited, along with the loan debt, from former district councils.
But it has had to spend the proceeds on services such as adult social care, following its warnings that it could go effectively bankrupt.
A council spokesperson said it was "clearly in the taxpayers' interest" to sell the properties rather than borrow more money.
More news stories for Somerset
Listen to the latest news for Somerset
The council's properties ranged from an M&S building in Yeovil, to offices in Bristol, business parks including Street Retail Park, a TK Maxx in Worcester, and an NCP car park in Bournemouth.
The district councils that were replaced by Somerset Council in 2023 along with the county council bought the properties with £298m in loans as part of an investment strategy taken by a number of English local authorities.
The £298m sum included fees and stamp duty as well as the cost of the properties.
The councils hoped to rent out the properties and use the money to run local public services.
However, just months after Somerset Council was created, it declared a "financial emergency" and said it would sell off 48 properties.
It was given special permission by the government to spend the proceeds on running day-to-day services like adult social care and children's services.
But the portfolio has significantly lost value due to falling market prices in recent years.
At the end of March 2024, the council's properties, including any already sold, were valued at £219m – a £78m loss on the initial investment.
As of 31 December 2024, Somerset Council has sold properties for £76m that cost £104m to buy, a £27m loss.
The £76m has been spent on day-to-day services in 2024/25, and the £104m debt remains with the council.
The council will also have lost the rental income from those properties.
Only around £18m of the debt arising from the property loans had, in March 2024, been paid off.
The purchases were largely funded by borrowing from the Public Works Loan Board, which the current council is responsible for repaying with interest. It makes these payments from its revenue budget.
Jonathan Carr-West, of the Local Government Information Unit think tank, said councils had been encouraged to invest in commercial property by the government but many found the purchases "exacerbated their financial problems".
The council spokesperson called for the government to take "urgent action to fix the system of funding local government which is fundamentally broken".
Follow BBC Somerset on Facebook and X. Send your story ideas to us on email or via WhatsApp on 0800 313 4630.
£47m cuts will impact on services - council leader
Council sells off more than £71m of property
Somerset Council says government cash not enough
Local authority declares financial emergency
Council may sell properties amid bankruptcy fears
Somerset Council investment strategy report
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Trends Shaping the $49.2 Billion Endoscopy Procedures Industry, 2025-2030: Includes Adjusted Forecasts and Analytics Relating to the Impact of Tariffs and Trade Turbulence
Endoscopy Procedures Market Dublin, June 13, 2025 (GLOBE NEWSWIRE) -- The "Endoscopy Procedures - Global Strategic Business Report" has been added to global market for Endoscopy Procedures was valued at US$34.3 Billion in 2024 and is projected to reach US$49.2 Billion by 2030, growing at a CAGR of 6.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Endoscopy Procedures market. Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Ambu A/S, Arthrex, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. The growth in the global endoscopy procedures market is driven by several factors that span epidemiological, technological, and systemic domains. At the core is the escalating global burden of gastrointestinal and pulmonary diseases, including colorectal cancer, gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and chronic obstructive pulmonary disease (COPD). The aging global population, combined with rising lifestyle-related risk factors such as obesity, smoking, and dietary patterns, is increasing the prevalence of these conditions and fueling demand for both diagnostic and interventional endoscopy. Moreover, the growing acceptance of regular cancer screening in high-risk populations is reinforcing the role of colonoscopy and upper GI endoscopy as preventive crucial driver is the technological sophistication of modern endoscopy platforms, which now support image-guided therapy, AI-assisted diagnostics, and real-time histological assessment. These capabilities are shortening procedure times, improving accuracy, and reducing the need for follow-up interventions, thereby appealing to both clinicians and payers. Health systems worldwide are recognizing the cost-effectiveness of early diagnosis and minimally invasive intervention, leading to favorable reimbursement structures and procedural mandates. In parallel, the rise of outpatient and ambulatory surgical centers is expanding procedural capacity without burdening hospital the emphasis on cross-specialty endoscopic training, coupled with increasing patient preference for non-surgical alternatives, is supporting long-term procedural volume growth. Medical device manufacturers are responding by launching modular, portable, and scalable platforms suitable for diverse practice settings, including rural clinics and smaller hospitals. These strategic product innovations, alongside government-backed screening initiatives and international collaborations in clinical education, ensure that endoscopy will remain central to the future of diagnostic and therapeutic care Insights: Market Growth: Understand the significant growth trajectory of the Disposable Endoscopes segment, which is expected to reach US$35.1 Billion by 2030 with a CAGR of a 7.2%. The Reusable Endoscopes segment is also set to grow at 3.9% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $9.3 Billion in 2024, and China, forecasted to grow at an impressive 10% CAGR to reach $10.2 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Key Questions Answered: How is the Global Endoscopy Procedures Market expected to evolve by 2030? What are the main drivers and restraints affecting the market? Which market segments will grow the most over the forecast period? How will market shares for different regions and segments change by 2030? Who are the leading players in the market, and what are their prospects? Some of the 41 companies featured in this Endoscopy Procedures market report include: Ambu A/S Arthrex, Inc. B. Braun Melsungen AG Boston Scientific Corporation CapsoVision, Inc. Carl Zeiss AG CONMED Corporation Cook Medical Ethicon Endo-Surgery, LLC Fortimedix Surgical B.V. Fujifilm Holdings Corporation HOYA Corporation (PENTAX Medical) Intuitive Surgical, Inc. Johnson & Johnson MedTech Karl Storz SE & Co. KG Medtronic plc MicroPort Scientific Corporation Olympus Corporation Richard Wolf GmbH Stryker Corporation This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include: Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs. Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015. Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends. Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape. Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players. Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities. Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage. Key Attributes Report Attribute Details No. of Pages 386 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $34.3 Billion Forecasted Market Value (USD) by 2030 $49.2 Billion Compound Annual Growth Rate 6.2% Regions Covered Global MARKET OVERVIEW Influencer Market Insights World Market Trajectories Tariff Impact on Global Supply Chain Patterns Endoscopy Procedures - Global Key Competitors Percentage Market Share in 2025 (E) Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E) MARKET TRENDS & DRIVERS Rising Global Incidence of GI, Pulmonary, and Urological Disorders Drives Demand for Endoscopy Procedures Shift Toward Early Diagnosis and Preventive Screening Throws Spotlight on Diagnostic Endoscopy Volumes Expansion of Ambulatory Surgical Centers Strengthens Business Case for High-Throughput Endoscopy Suites Technological Advancements in Flexible and Capsule Endoscopes Enhance Patient Comfort and Diagnostic Yield Investment in High-Definition and 4K Endoscopy Platforms Fuels Clinical Adoption in Complex Procedures Increased Use of AI-Assisted Polyp Detection and Lesion Characterization Drives Innovation in Procedure Efficiency Integration of Endoscopy With EHR and PACS Systems Supports Streamlined Reporting and Workflow Growth in Endoscopic Therapeutics for GI Bleeds, Obesity, and Strictures Expands Procedure Complexity Rising Colorectal Cancer Screening Initiatives by Governments Propel Growth in Colonoscopy Volume Reimbursement Approvals for Bariatric and Esophageal Endoscopic Treatments Promote Procedural Expansion Emphasis on Reprocessable, Single-Use, and Hybrid Endoscopes Enhances Infection Control Standards Global Aging Population and Rise in Comorbid Conditions Fuel Diagnostic Endoscopy Demand Surge in Pulmonary Endoscopy and Bronchoscopy Procedures With EBUS Drives Volume in Respiratory Care Growing Preference for Sedation-Free and Office-Based Endoscopy Increases Patient Throughput Emergence of AI-Powered Decision Support Tools Enhances Clinical Workflow During Procedures Expansion of Endoscopic Oncology Procedures Including EMR and ESD Expands Therapeutic Applications Public Awareness Campaigns and Screening Recommendations Spur Uptake of Endoscopic Exams Rapid Growth in Medical Tourism in Asia and Latin America Bolsters Demand for Elective Endoscopy Cross-Specialty Use in ENT, Gynecology, and Orthopedics Supports Broader Endoscopic Equipment Adoption OEM-Clinic Collaborations Drive Investment in Endoscopy Center Design and Staff Training For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Endoscopy Procedures Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
34 minutes ago
- Yahoo
Warner Bros. Discovery (WBD) Pops 5% on Breakup Plan
Warner Bros. Discovery (WBD, Financials) led the S&P 500 Wednesday, rising 5% after announcing it will break into two public companiesone for streaming and studios, another for cable networks. Warning! GuruFocus has detected 4 Warning Signs with WBD. CEO David Zaslav will lead the new content-focused business, while CFO Gunnar Wiedenfels will head the networks unit. The company hopes the split, set for mid-2026, will sharpen strategy and boost value. The news landed well with investors, though the stock remains down about 15% for the year. Analysts say the move could unlock value, especially as the company pivots away from declining cable revenues. Still, there's baggage. Credit agencies downgraded WBD's debt to junk status, pointing to its $37 billion load. A $17.5 billion bridge loan from JPMorgan will help ease the split, but questions remain. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
36 minutes ago
- Yahoo
5 Under-the-Radar Stocks To Consider Buying This Summer
When it comes to investing your hard-earned cash, you may not always factor in growth potential or dividend yields. Yet, as the summer heats up, savvy investors are scanning the market for overlooked opportunities — companies quietly innovating or recovering under the radar, away from the hype of big tech or meme stocks. Check Out: For You: If you're looking to diversify your portfolio with potential breakout candidates, these five under-the-radar stocks could be worth a closer look this summer. Stock price: $7.58 Market cap: $898.7 million 52-week high: $7.92 52-week low: $0.50 Sector: Consumer discretionary Many analysts give this online warehouse for used vintage, designer and second-hand clothing a consensus rating of buy. You'll want to consider this company for investing in both your wardrobe and portfolio, as business for high-end clothing with more frugal price tags is booming. Good To Know: Stock price: $471.84 Market cap: $21.49 billion 52-week high: $544.93 52-week low: $145.05 Sector: Education tech While most investors are focused on artificial intelligence (AI) giants, Duolingo has been quietly leveraging AI to improve language learning and user engagement. Its gamified app continues to grow its global user base, especially in non-English speaking markets. With strong brand recognition, growing subscription revenue, and increasing profitability, DUOL is positioning itself as more than just a niche app — it's building an ecosystem of learning. This summer it is expanding into math and music learning for potential new revenue streams, as well. Stock price: $239.33 Market cap: $3.20 billion 52-week high: $240.00 52-week low: $28.31 Sector: Digital banking This summer could be a great time to buy this stock before its price skyrockets, as analysts have been raising their price targets for DAVE, reflecting a positive outlook on the company's future performance. It also currently has a 'buy' or 'strong buy' rating. Stock price: $141.19 Market cap: $4.78 billion 52-week high: $177.37 52-week low: $55.00 Sector: Healthcare Another stock with a growth rate that is gaining momentum is TMDX. Multiple analysts give this stock a 'buy' to 'moderate buy' rating, even though it's a lesser-known contender in the healthcare industry. Stock price: $23.38 Market cap: $1.29 billion 52-week high: $23.95 52-week low: $2.52 Sector: Technology Expert analysts expect this stock to rise thanks to the rising technical trend it's linked to (autonomous navigation), as well as savvy and strategic partnerships and collaborations. It has a 'buy' to 'strong buy' rating. Editor's note: Stock prices are accurate as of June 12, 2025. More From GOBankingRates How Much Money Is Needed To Be Considered Middle Class in Every State? This article originally appeared on 5 Under-the-Radar Stocks To Consider Buying This Summer Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
